XML 96 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jan. 31, 2020
Jan. 31, 2019
Jan. 31, 2020
Jan. 31, 2019
Income Statement [Abstract]        
Net sales $ 34,225 $ 32,372 $ 113,283 $ 111,802
Cost of products sold 28,947 27,142 94,743 91,325
Gross profit 5,278 5,230 18,540 20,477
Operating expenses 7,350 5,232 19,875 16,810
Operating earnings (loss) (2,072) (2) (1,335) 3,667
Other income (loss) (29) 113 43 279
Interest expense, net (150) (76) (452) (258)
Earnings (loss) before income taxes (2,251) 35 (1,744) 3,688
Income tax expense (benefit) (350) 20 1,822 803
Net earnings (loss) (1,901) 15 (3,566) 2,885
Less: net earnings attributable to the noncontrolling interest 17 37 59 86
Net earnings (loss) attributable to Kewaunee Scientific Corporation $ (1,918) $ (22) $ (3,625) $ 2,799
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders        
Basic (in dollars per share) $ (0.70) $ (0.01) $ (1.32) $ 1.02
Diluted (in dollars per share) $ (0.70) $ (0.01) $ (1.32) $ 1.00
Weighted average number of common shares outstanding        
Basic 2,750 2,744 2,750 2,741
Diluted 2,750 2,794 2,750 2,799